Trial Profile
A prospective, randomised, double-blind, placebo-controlled trial evaluating the effects of mycophenolate mofetil (MMF) on surrogate markers for atherosclerosis in female patients with systemic lupus erythematosus
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 30 Sep 2019
Price :
$35
*
At a glance
- Drugs Mycophenolate mofetil (Primary)
- Indications Coronary disorders; Systemic lupus erythematosus
- Focus Therapeutic Use
- Acronyms MISSILE
- 29 May 2014 New trial record